IL37431A - Pharmaceutical compositions containing derivatives of thiazolino(3,2-a)pyrimidin-5-one,certain such novel derivatives and their preparation - Google Patents
Pharmaceutical compositions containing derivatives of thiazolino(3,2-a)pyrimidin-5-one,certain such novel derivatives and their preparationInfo
- Publication number
- IL37431A IL37431A IL37431A IL3743171A IL37431A IL 37431 A IL37431 A IL 37431A IL 37431 A IL37431 A IL 37431A IL 3743171 A IL3743171 A IL 3743171A IL 37431 A IL37431 A IL 37431A
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- preparation
- derivatives
- methyl
- thiazolino
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 title description 2
- BDTRIDKONHOQQN-UHFFFAOYSA-N 4h-pyrimidin-5-one Chemical compound O=C1CN=CN=C1 BDTRIDKONHOQQN-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 150000002466 imines Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- GKKZMYDNDDMXSE-UHFFFAOYSA-N Ethyl 3-oxo-3-phenylpropanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC=C1 GKKZMYDNDDMXSE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Description
ft Pharmaceutical compositions containiag derivatives of certain novel derivatives and r invention relates to particularly analgesic compositions as active a of the general formula illustrated in 1 of the accompanying in hydrogen or an alkyl and A is a phenyl group optionally substituted with alkoxy or triflusromethyl or a or alkyl or a pharmaceutically acceptable acid addition salt the compounds of formula are optionally further suhstituted at positions 2 3 one at most positions or is suhstituted in addition to position I should he noted that when a suhstltuent is present at the compounds may exist in the form of stereoisomers and the invention includes both the forms and the active the preceding the alkyl and alkoxy groups are advantageously lover groups of these in particular containing from 1 to 4 compounds of formula herein are novel except those in which s and are each hydrogen and A is a methyl or a phenyl grou and and are each hydrogen and and are each a methyl To prepare compounds a process illustrated in 2 of the accompanying and which is also included within the scope of the may he Shis process comprises condensing a in vhich R and have the vith a ester of the in and A have the and B is a lover alkyl and then optionally salifying resulting compound may be used in free or salt In the latter the is released in situ by an alkaline This condensation is advantageously conducted vithin an organic solvent such as xylene or It is ted by for example at the refluxing temperature of the condensation may also be carried out vithout a by heating the mixture to The folloving examples illustrate the invention limiting Example I Synthesis of A R R2 Code Into a 1 litre flask fitted vith a stirring a cooler and a heatin are added 100 g dine R R2 and 300 ml The mixture is heated until it is and 190 g ethyl A B are then added After re luxing 5 the reaction mixture is left aside overnight at room The resulting talline material is suction washed with ethanol and then recrystallized from ethyl ether after which it is dried in vacuo to give g of Analysis Total nitrogen Calculated Found The resulting base may be converted to the as 20 g are dissolved in 130 ml at room 40 ml of 6N hydrochloric acid in ethanol solution are then with The mixture rapidly sets to a It is left aside during one hour at room and then one hour in an It is then suction washed once with chloroform and then twice with absolute after which it is dried in an oven at to give 22 g of 3 Calculated Found Total nitrogen Ionized chlorine Example II Alternative synthesis of A Code is dissolved in ethyl with The reaction mixture is then to incipient boiling vhich is maintained for a few The resulting orange solution is poured over 50 g It is then stirred during 15 A yellow product precipitates It is filtered and washed with The insoluble is taken up into an by washed with ether and dried in to give g of crystalline depression on admixture with the product obtained according to the procedure of Example Analysis Calculated Found Basic nitrogen Example III Preparation of A R 2 HjCode and acetate A B are mixed with xylene The reaction mixture is refluxed 7 After allowing to overnight at room a crude material is collected and is then recrystallized from chloroform to give g of Calculated Found Total nitrogen Example IV Preparation of A R Code To a are added R and ethyl benzoylacetate A C B vhich are dissolved in The mixture is vith 6 hours and is then left aside overnight at room The sulting material is vashed three times with suction filtered and then recrystallized from 100 ml to give 16 g of Analysist Calculated Found Total nitroge Example V Preparation of I t A 3 Code and ethyl A B ne and are then refluxed at room the ting crystals are suction vashed with xylene and vith On recrystallization from g of are Calculated Found Total nitrogen The constitution and physical properties of compounds obtained according to the examples described above and of othe compounds prepared in a similar manner are summarized in the following In this Table are also reported data relating to the analgesic activity of compounds as determined by one of the conventional testing procedures for this the Mice are given a single intraperitoneal injection of ml of 6 acetic acid The compound to be tested is administered orally at a dosage of one prior to the acetic acid The number of tic vrithing movements induced by pain is counted during the 15 minutes that follow the acetic acid The magnitude of the action of each compound described is expressed using one to four representing maximum r The analgesic activity of compounds permits their tion in human said compounds being administrable by the parenteral or rectal route at a daily dosage regimen generally comprised between 300 and 900 For such the compounds are formulated as therapeutical compositions with the vehicles or excipients suitable for these various routes of The formulated in unit dosage such as sitories and contain preferably from 100 to 300 mg of compound insufficientOCRQuality
Claims (1)
1. 0 particular compositions comprising a of the general formula in which and are each hydrogen or an alkyl and A a phenyl optionally substituted with or trifluoromethyl or a methyl or or an acid addition salt together a pharmaceutically acceptable of formula I in Claim provided when and then A is not a methyl or a phenyl and when and are each hydrogen and is a methyl then is not a methyl and their addition Compounds as claimed in wherein the alkyl and alkoxy groups are lower groups of this Compounds as claimed in Claim 2 or wherein one at most of substituents and is than and its r 10a 6 its and its 3 and its and its and its 11 a and its tolvl and its and its and its and its salts 3 and its and its and its and its 5 and its and its and its 3 232 and its and its and its Process for the preparation of compounds as claimed in 2 claims comprising condensing a of the formula in R and have the with a ester of the in and Λ have the and B is a lower alkyl then optionally salifying the resulting Process as claimed in claim the lidine is used ee salt in the latter case the imine being released situ by an Process as claimed in claim wherein the condensation is conducted in an organic solvent Process as claimed claim wherein the condensation is conducted without by heating the mixture of reagents to Process for the preparation of compounds as claimed in 2 claims substantially as described with reference to the insufficientOCRQuality
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3918970 | 1970-08-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL37431A0 IL37431A0 (en) | 1971-11-29 |
| IL37431A true IL37431A (en) | 1974-10-22 |
Family
ID=10408188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL37431A IL37431A (en) | 1970-08-14 | 1971-08-03 | Pharmaceutical compositions containing derivatives of thiazolino(3,2-a)pyrimidin-5-one,certain such novel derivatives and their preparation |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5116437B1 (en) |
| AT (1) | AT305279B (en) |
| AU (1) | AU3231071A (en) |
| BE (1) | BE770873A (en) |
| CA (1) | CA925868A (en) |
| CH (1) | CH542231A (en) |
| DE (1) | DE2140601C3 (en) |
| DK (1) | DK129718B (en) |
| ES (1) | ES394727A1 (en) |
| FI (1) | FI52096C (en) |
| FR (1) | FR2102254B1 (en) |
| GB (1) | GB1306558A (en) |
| IE (1) | IE35491B1 (en) |
| IL (1) | IL37431A (en) |
| IS (1) | IS918B6 (en) |
| LU (1) | LU63700A1 (en) |
| NL (2) | NL149177B (en) |
| NO (1) | NO132760C (en) |
| OA (1) | OA03905A (en) |
| SE (1) | SE380271B (en) |
| ZA (1) | ZA715194B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL129612B1 (en) * | 1980-07-24 | 1984-05-31 | Rhone Poulenc Ind | Process for preparing novel derivatives of 2,3,6,7-tetrahydrothiazole/3,2-a/pirymidin-5-one |
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| JPS5980072U (en) * | 1982-11-19 | 1984-05-30 | 株式会社東洋製作所 | Warehouse door opening/closing device |
| JPS6354797U (en) * | 1986-09-29 | 1988-04-12 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1275804A (en) * | 1969-07-03 | 1972-05-24 | Seperic | Improvements in or relating to new sulphur containing derivatives of pyrimidine, their preparation and their applications |
-
1970
- 1970-08-14 GB GB3918970A patent/GB1306558A/en not_active Expired
-
1971
- 1971-07-08 FR FR7125051A patent/FR2102254B1/fr not_active Expired
- 1971-08-03 BE BE770873A patent/BE770873A/en unknown
- 1971-08-03 IS IS2024A patent/IS918B6/en unknown
- 1971-08-03 IL IL37431A patent/IL37431A/en unknown
- 1971-08-04 ZA ZA715194A patent/ZA715194B/en unknown
- 1971-08-04 IE IE986/71A patent/IE35491B1/en unknown
- 1971-08-05 SE SE7110021A patent/SE380271B/en unknown
- 1971-08-05 CH CH1155771A patent/CH542231A/en not_active IP Right Cessation
- 1971-08-09 OA OA54327A patent/OA03905A/en unknown
- 1971-08-11 FI FI712245A patent/FI52096C/en active
- 1971-08-11 LU LU63700D patent/LU63700A1/xx unknown
- 1971-08-12 AU AU32310/71A patent/AU3231071A/en not_active Expired
- 1971-08-12 ES ES394727A patent/ES394727A1/en not_active Expired
- 1971-08-13 NO NO3028/71A patent/NO132760C/no unknown
- 1971-08-13 CA CA120534A patent/CA925868A/en not_active Expired
- 1971-08-13 AT AT711771A patent/AT305279B/en active
- 1971-08-13 JP JP46061591A patent/JPS5116437B1/ja active Pending
- 1971-08-13 DK DK398471AA patent/DK129718B/en unknown
- 1971-08-13 DE DE2140601A patent/DE2140601C3/en not_active Expired
- 1971-08-13 NL NL717111222A patent/NL149177B/en not_active IP Right Cessation
-
1976
- 1976-01-28 NL NL7600885A patent/NL7600885A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7111222A (en) | 1972-02-16 |
| DK129718B (en) | 1974-11-11 |
| CA925868A (en) | 1973-05-08 |
| GB1306558A (en) | 1973-02-14 |
| OA03905A (en) | 1975-08-14 |
| ZA715194B (en) | 1972-04-26 |
| AU3231071A (en) | 1973-02-15 |
| FI52096B (en) | 1977-02-28 |
| NO132760B (en) | 1975-09-22 |
| IL37431A0 (en) | 1971-11-29 |
| FR2102254A1 (en) | 1972-04-07 |
| AT305279B (en) | 1973-02-26 |
| BE770873A (en) | 1971-12-16 |
| ES394727A1 (en) | 1974-02-16 |
| CH542231A (en) | 1973-09-30 |
| LU63700A1 (en) | 1971-12-17 |
| DE2140601A1 (en) | 1972-02-17 |
| IS918B6 (en) | 1975-12-24 |
| DK129718C (en) | 1975-04-28 |
| NO132760C (en) | 1975-12-29 |
| FI52096C (en) | 1977-06-10 |
| NL7600885A (en) | 1976-04-29 |
| IE35491L (en) | 1972-02-14 |
| IS2024A7 (en) | 1972-02-15 |
| SE380271B (en) | 1975-11-03 |
| IE35491B1 (en) | 1976-03-03 |
| NL149177B (en) | 1976-04-15 |
| FR2102254B1 (en) | 1976-04-16 |
| DE2140601C3 (en) | 1975-02-13 |
| DE2140601B2 (en) | 1974-05-30 |
| JPS5116437B1 (en) | 1976-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6032620B2 (en) | Novel cyanacetanilide derivative and its production method | |
| EP0198456B1 (en) | 1,7-naphthyridine derivatives and medicinal preparations containing same | |
| US4960773A (en) | Xanthine derivatives | |
| US3888983A (en) | Derivatives of thiazolino-pyrimidin-6-ones, in inducing analgesia | |
| US3192253A (en) | N-substituted methoxyphenoxy-ethylamines | |
| IL37431A (en) | Pharmaceutical compositions containing derivatives of thiazolino(3,2-a)pyrimidin-5-one,certain such novel derivatives and their preparation | |
| US3971814A (en) | Benzo(b)thiophene derivatives | |
| US3953461A (en) | Amino derivatives of thiazolo[5,4-b]pyridine-6-carboxylic acids and esters | |
| JPS6024794B2 (en) | Oxadiazolopyrimidine derivatives | |
| CS240982B2 (en) | Production method of pyrrolidine derivatives | |
| US4500708A (en) | Benzothiazine derivatives | |
| KR880001298B1 (en) | Preparation of benzoyl-phenyl-piperidine derivatives | |
| US3029247A (en) | Certain tetrahydro-beta-carbolines | |
| US3523120A (en) | Piperonyl-piperazine compounds | |
| US3824234A (en) | 7,8,9,10-tetrahydro-2-methoxy-7-morpholinomethylcyclohept(b)indol-6(5h)-one | |
| US5098919A (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| US4018793A (en) | Benzo (b) thiophene derivatives | |
| EP0025965A2 (en) | Organogermanium compounds, a method for producing them and pharmaceutical compositions comprising them | |
| US3876639A (en) | Thiazolino-pyrimidin-5-one derivatives, process for their preparation and applications thereof | |
| US2802826A (en) | Octahydro-pyrido [4, 3-d] pyrimidine compounds | |
| KR900000968B1 (en) | 1,2-dithiol-3-thione derivative composition and their preparation | |
| US3420839A (en) | Aminomethyl pyrazolone derivatives of nicotinamide | |
| CA1036605A (en) | Amino derivatives of pyrido (3,4-b) pyrazine carboxylic acids and esters | |
| US3991082A (en) | 4-Substituted-2,3-dihydro-1-benzoxepin-3,5-diones and tautomers | |
| US4056526A (en) | Benzo(b)thiophene derivatives |